Study of Post Compression Parameters of Various Marketed Paracetamol Tablets in India
Paracetamol belongs to the class of antipyretic and analgesic. Various brands of some dosage forms are available in the market with a common claim that they are all bioequivalent. The main objective of the present experiment was to evaluate post compression parameters of various brands of paracetamol tablets containing 650 mg of drug and to determine whether all the formulations used were equivalent or significantly different. Paracetamol of 650 mg standard tablets from different manufacturers were selected in the studies. The post compression parameters like weight variation, friability, hardness, weight variation, disintegration, dissolution profiles were found to be varying but within the prescribed limit.
Binega G and Wondimsigegn D et al.,(2013); Analysis and comparison of paracetamol tablets dispensed in legal dispensaries and non pharmaceutical shops in Gondar town ,north west ,Ethiopia; Int J of Phar and Ind Res; 3(2); 144-151
D.R Jadge and A.N Despande et al., (2014); Comparative invitro evaluation of different brands of paracetamol tablets marketed in Maharashtra state; Int J of Pharma Sci and Health Care; 4(4); 40-7
https://www.drugbank.ca/drugs/DB00316 ( Cited on 17/12/18 at 2.45 PM)
Kar A and Amin MN et al., (2015) ; Quality analysis of different marketed brands of paracetamol available in Bangladesh ; Int Cur pharm J; 4(9); 432-435
Mathur N and Kumar R et al., (2015); Evaluation of quality control parameters on various brands of paracetamol tablet formulation ;World J of Pharm and Pharma Sci ; 4(7); 976-984
Nayak AK (2010); Comparative in vitro dissolution assessment of some commercially available paracetamol tablets; Int J of Pharma Sci Review and Res; 2(1); 29-30.
Rahman ZU and Khan I et al.,2013; Post-Market In-Vitro Comparative Evaluation of Quality Control Parameters of Paracetamol Compressed Tablets Manufactured in Local Industrial Zones of Kpk Pakistan; The Pharma innovation J; 2(3); 11-15
Siew A (2016) ; dissolution testing; Pharma Tech ;40(11); 56-64